Description
Pfizer Ventures invests globally in innovative biopharmaceutical companies advancing breakthrough medicines that have the potential to transform patients' lives, providing long-term perspective, deep scientific insight, and thoughtful engagement as companies grow and scale. It focuses on transformative therapeutics across core areas including Oncology, Inflammation & Immunology, Cardiovascular, Metabolic/Obesity, and Vaccines, as well as platform technology companies with diversified pipelines aligned to Pfizer's strategic interests. The firm invests across the private company lifecycle, from Seed through IPO, with emphasis on early-stage new investments, typically committing $5-20 million initially, leading or joining investor syndicates, and seeking board representation commensurate with its investment level. Portfolio companies benefit from strategic and operational guidance, access to Pfizer's scientific leaders, clinical insight, and potential strategic collaborators, while maintaining flexibility and independence.